Goldman Sachs Group »

Tourmaline Bio shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $236k 9.0k 26.18

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Tourmaline Bio

Blue Owl Capital Holdings
Jennison Associates
QVT Financial
Vanguard Group
Braidwell
venBio Select Advisor
Dr. Jeffrey R. Jay, M.D.
Qiming U.S. Ventures Management
Vivo Capital
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Susquehanna International
Artal Group
AlphaCentric Advisors

View all funds holding Tourmaline Bio